Sleep apnoea treatment business ResMed has launched its new AirTouch N30i product – manufactured at Bella Vista, New South Wales – in Australia, describing the new nasal mask as combining softness, breathability, and a high-performance seal.
The company’s first fully-fabric mask is “a fabric-wrapped frame featuring a soft, breathable, and moisture-wicking design”, ResMed said on Monday.
Justin Leong, ResMed’s chief product officer, added: “We are excited to introduce the AirTouch N30i, a mask that redefines comfort with its soft, natural feel and sleek, modern design.
“It sets a new standard in CPAP masks, helping more people stay committed to their therapy and achieve better sleep while offering a refined aesthetic that is as pleasing to look at as it is to wear.”
ResMed is listed on both the ASX and the New York Stock Exchange, and has a global headquarters in San Diego, which it opened in 1992. Airtouch N30i was launched in the US in late-September.
ResMed was established in Sydney in 1989, based on the continuous positive airway pressure (CPAP) invention to treat chronic obstructive sleep apnoea (OSA.) Today it makes cloud-connected medical devices and accessories to treat sleep apnea, COPD, and other chronic diseases for 140 countries, and employs approximately 10,000.
According to company, about one in five people have a diagnosed history of sleep apnoea.
Last week ResMed reported that its revenue grew by 11 per cent (on a constant currency basis) for the first quarter FY25, reaching $US 1.2 billion.
Picture: supplied
Further reading
ResMed sales up on demand for sleep apnoea devices
ResMed – from unwanted idea, to Peter Farrell’s great legacy
Australia’s niche champions – ResMed, 5% inspiration, 95% perspiration